News & Events

Press releases

Pneumagen Announces Neumifil™ is Efficacious In an Established Model of COVID-19 Infection

READ MORE...

Pneumagen Announces £2.5m fundraising to advance universal treatment for viral respiratory infections into the clinic this year

READ MORE...

Pneumagen’s Neumifil for combating COVID-19 featured in SCRIP’s 10 to watch at BIO-Europe Digital

READ MORE...

Pneumagen Announces Scientific Advisory Board and Development Team Appointments

READ MORE...

Pneumagen Announces £4m fundraising and Commits to Clinical Trial Development for COVID-19

READ MORE...

Pneumagen Ltd’s Recent COVID-19 Data Covered by BBC’s “The Nine”

READ MORE...

Pneumagen Ltd Announces Positive Anti–Viral Activity for Novel Glycan Approach in Preventing COVID–19 Infections

READ MORE...

Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections

READ MORE...

Pneumagen Presents Poster on Multivalent Sialic Acid-binding Proteins as a Novel Preventative and Treatment of RSV at RSVVW 2019

READ MORE...

Event information

Bio€quity Europe in Dublin | May 14th – 16th 2023

READ MORE...

Biotech Showcase / JPM Week | January 9th – 11th 2023

READ MORE...

Jefferies London Healthcare Conference | November 15th – 17th 2022

READ MORE...

BIO-Europe in Leipzig | October 24th – 26th 2022

READ MORE...

BIO International Convention in San Diego | June 13th – 16th 2022

READ MORE...

Bio€quity Europe in Milan | May 16th – 18th 2022

READ MORE...

BioTrinity 2022 in London | April 26th – 27th 2022

READ MORE...

BIO-Europe Spring Digital | March 28th – 30th 2022

READ MORE...